PhD avhandlinger
Fullførte PhD avhandlinger etter år.
Hovedinnhold
2023
| Kristine E. Fasmer | MRI and 2-[18F]FDG PET/CT for staging, prognostication, and tailoring treatment in endometrial cancer. |
2022 | |
| Hege F. Berg | Organoid models and novel biomarkers for improved treatment of endometrial cancer. |
2021 | |
Novel preoperative biomarkers and evaluation of altered treatment strategies to improve outcome for endometrial cancer patients. | |
2020 | |
| Hilde R. Engerud | Molecular markers to predict prognosis and guide therapy in endometrial cancer |
2019 | |
| Sigmund Ytre-Hauge | Advanced imaging biomarkers in endometrial cancer |
2018 | |
| Tina Fonnes | Preclinical models and molecular biomarkers – tools to improve treatment in endometrial carcinoma |
2017 | |
| Anna Berg | Molecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment |
| Karen K. Mauland | Context-related biomarkers in endometrial cancer – a study with focus on obesity and genomic alterations |
| Mari K. Halle | Molecular alterations suggesting new treatment strategies in uterine carcinomas |
2013 | |
| Elisabeth Wik | Endometrial carcinoma: a step closer to individualized therapy? Exploring transcriptional alterations in relation to prognostic biomarkers |
| Even Birkeland | Mutations and gene amplifications in Endometrial Carcinomas. “Clinical characteristics and potential targets for therapyrelated to KRAS, MYC, ATAD2, PIK3CA and FGFR2 alterations |
2012 | |
| Jone Trovik | Endometrial cancer; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers |
20.06.2024